Ren Dongyue, He Lin, Pang Xiaoling
Department of Emergency, the Fourth Affiliated Hospital of China Medical University, Shenyang, People's Republic of China.
Good Clinical Practice Institution, the Fourth Affiliated Hospital of China Medical University, Shenyang, People's Republic of China.
Diabetes Metab Syndr Obes. 2022 Sep 3;15:2705-2712. doi: 10.2147/DMSO.S374451. eCollection 2022.
This study aimed to investigate the association of CLTA-4 gene polymorphism with Type 1 and 2 diabetes mellitus (DM) (T1DM and T2DM) in the Han population of northern China.
A total of 234 Chinese Han DM patients and 187 non-diabetic subjects were included in the study. Two gene polymorphisms of the CLTA-4, including CTLA-4+49A/G (rs231775) and CTLA4-318C/T (rs5742909), were studied using polymerase chain reaction-restriction endonuclease fragment length polymorphism (PCR-RFLP) analysis. Chi-square analysis and Student's -test were performed to determine the distribution of the gene polymorphism and alleles at the locus of CTLA4-318C/T and CTLA4+49A/G among T1DM and T2DM patients with or without diabetic ketosis (DK), diabetic nephropathy (DN) or autoantibodies (Ab).
Our results indicated that the distribution frequencies of genotypes and alleles at the CTLA-4+49A/G and CTLA4-318C/T loci of T1DM patients were not significantly different from those of the controls. However, the distribution frequencies of genotypes and alleles at the CTLA-4+49A/G loci of T2DM patients were significantly different from the controls (P=0.024 for genotypes and P=0.004 for A and G alleles). Besides, the A and G alleles at the CTLA4-318C/T loci of T2DM DK+ patients showed significantly different distribution frequencies compared to those of the T2DM DK patients (P=0.001).
Our data suggest that the gene polymorphisms of CTLA-4, including CTLA-4+49A/G and CTLA4-318C/T, are important predictors of DM. CTLA-4 may be a susceptibility gene for T2DM. Patients with T2DM carrying the T allele at the CTLA4-318 C/T locus are more predisposed to diabetic ketosis.
本研究旨在探讨中国北方汉族人群中细胞毒性T淋巴细胞相关抗原4(CLTA-4)基因多态性与1型和2型糖尿病(T1DM和T2DM)的关联。
本研究共纳入234例中国汉族糖尿病患者和187例非糖尿病受试者。采用聚合酶链反应-限制性内切酶片段长度多态性(PCR-RFLP)分析研究CLTA-4的两个基因多态性,包括CTLA-4 +49A/G(rs231775)和CTLA4 -318C/T(rs5742909)。进行卡方分析和t检验,以确定CTLA4 -318C/T和CTLA4 +49A/G位点的基因多态性和等位基因在有或无糖尿病酮症(DK)、糖尿病肾病(DN)或自身抗体(Ab)的T1DM和T2DM患者中的分布情况。
我们的结果表明,T1DM患者CTLA-4 +49A/G和CTLA4 -318C/T位点的基因型和等位基因分布频率与对照组无显著差异。然而,T2DM患者CTLA-4 +49A/G位点的基因型和等位基因分布频率与对照组有显著差异(基因型P = 0.024,A和G等位基因P = 0.004)。此外,与T2DM DK患者相比,T2DM DK+患者CTLA4 -318C/T位点的A和G等位基因分布频率有显著差异(P = 0.001)。
我们的数据表明,CTLA-4的基因多态性,包括CTLA-4 +49A/G和CTLA4 -318C/T,是糖尿病的重要预测指标。CTLA-4可能是T2DM的易感基因。CTLA4 -318 C/T位点携带T等位基因的T2DM患者更容易发生糖尿病酮症。